Gynecomastia in a male after dasatinib treatment for chronic myeloid leukemia

Leukemia. 2008 Nov;22(11):2127-8. doi: 10.1038/leu.2008.106. Epub 2008 May 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Dasatinib
  • Gynecomastia / chemically induced*
  • Gynecomastia / drug therapy
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Selective Estrogen Receptor Modulators / therapeutic use
  • Tamoxifen / therapeutic use
  • Thiazoles / adverse effects*
  • Thiazoles / therapeutic use
  • Treatment Outcome

Substances

  • Protein Kinase Inhibitors
  • Pyrimidines
  • Selective Estrogen Receptor Modulators
  • Thiazoles
  • Tamoxifen
  • Dasatinib